FDA Approves Abbott’s Vysis ALK FISH Test for NSCLC Therapy Selection
Methadone Uses: FDA approves Abbott’s Vysis ALK FISH test for NSCLC therapy selection
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Methadone Uses – Yahoo! News Search Results
More Methadone Uses Information…